Showing results (11-20 of 403) with videos related to
Sort By:
Pageof 41
Cancer Letters|June 2, 2005
Prospects for therapeutic inhibition of neuroblastoma angiogenesisSuzanne Shusterman, John M MarisJournal of Patient Experience|October 31, 2022
Patient-Centered Care and Healthcare Consumerism in Online Healthcare Service Advertisements: A Positioning AnalysisSung-Yeon Park, Gi Woong Yun, Sarah Friedman, et al.Health Communication|March 22, 2022
Analysis of Direct-To-Consumer Healthcare Service Advertisements on Television: An Application of the Patient Expectation FrameworkSung-Yeon Park, Kylie Hill, Gi Woong Yun, et al.Cancer Discovery|March 12, 2013
Targeting MYCN: a good BET for improving neuroblastoma therapy?Robert W Schnepp, John M MarisCancer Cell|February 21, 2012
PI3King on MYCN to improve neuroblastoma therapeuticsMichael D Hogarty, John M MarisClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2014
Identifying rare events in rare diseasesEdward F Attiyeh, John M MarisCancer|November 6, 2015
Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterationsKristopher R Bosse, John M MarisMolecular Oncology|December 14, 2020
Refining immunotherapeutic approaches to high-risk neuroblastoma based on tumor genomic profilesLiron D Grossmann, John M MarisClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2012
New strategies in refractory and recurrent neuroblastoma: translational opportunities to impact patient outcomeKristina A Cole, John M MarisNature Reviews. Cancer|February 18, 2015
Revisiting tissue specificity of germline cancer predisposing mutationsJohn M Maris, Alfred G KnudsonPageof 41